LAS VEGAS, Feb. 07, 2017 (GLOBE NEWSWIRE) -- THC Therapeutics has received approval with FINRA for a name change from Harmonic Energy (Ticker symbol ASUV) to THC Therapeutics, with a new ticker symbol (OTCBB:THCT). We are very excited to be trading under such a brand specific trading symbol. THC Therapeutics Investor Relations page is now available here; this page provides live, continuously updated stock and news information.
"We are A New Kind of Cannabis Company actively seeking partnerships, mergers and acquisitions in the cannabis and health and healing industries,” says Brandon Romanek the Founder & CEO. “As February and March unfold, we plan on beginning the process of hiring highly skilled professionals to fill open positions in our rapidly expanding enterprise. I look forward to an amazing future for our company and shareholders."
The first of many products in THC Therapeutics’ pipeline is the dHydronator®, a sanitizing herb dryer with multiple design, function and usage patents pending. Traditionally cannabis drying times vary from 10-14 days, but the proprietary multi-purpose dHydronator technology is proven to reduce this time down to 12-14 hours. The dHydronator can dry and sanitize all herbs, including basil, oregano, rosemary and more. We are in the process of researching and adding depth to this exciting product prior to release. “Because of the vast applications for this product, I see great potential in the Home and Garden, Agriculture and Marijuana industries,” says Romanek. More information on the dHydronator can be found here.
A new 2016 Arcview Market Research study shows North American Marijuana sales to top $20.2 Billion by 2021. The executive summary of this groundbreaking report was released on January 16th at Arcview’s private Investor Forum in L.A. This first of its kind report finds that regulated marijuana sales in North America totaled $6.7 billion in 2016, a 30 percent increase from 2015. Sales are projected to grow at a compound annual growth rate of 25 percent, from $6.7 billion in 2016 to an estimated $20.2 billion by 2021.
About THC Therapeutics:
THC Therapeutics is a forward-thinking publicly traded health and healing company in the cannabis industry that has "Better Health through the Science of Nature" as their mission statement. The company is dedicated to innovating new methods and refining current industry standards in the cannabis market. THC Therapeutics plans for future growth include cultivation, dispensing, extractions, edibles, personal wellness centers and flotation therapy. For more information, visit THCTherapeutics.com.
Forward-Looking Statements Disclosure:
This press release may contain "forward-looking statements" within the meaning of the federal securities laws. In this context, forward-looking statements may address the Company's expected future business and financial performance, and often contain words such as "anticipates," "beliefs," "estimates," "expects," "intends," " plans," "seeks," "will," and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward-looking statements based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.
Follow Brandon Romanek on Twitter:
Twitter @BrandonRomanek
Follow THC Therapeutics on Facebook and Twitter:
Twitter @THCTherapeutics
Facebook @THCTherapies
We Tweet and post every day at 4:20 PM PST